- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/04 - Drugs for genital or sexual disordersContraceptives for inducing labour or abortionUterotonics
Patent holdings for IPC class A61P 15/04
Total number of patents in this class: 63
10-year publication summary
|
0
|
2
|
2
|
5
|
5
|
6
|
3
|
2
|
7
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dilafor AB | 20 |
11 |
| Native Microbials, Inc. | 72 |
8 |
| Ferring B.V. | 714 |
4 |
| Ache Laboratorios Farmaceuticos S/A | 23 |
2 |
| Nippon Shinyaku Co., Ltd. | 325 |
2 |
| Nordic Group B.V. | 43 |
2 |
| Repros Therapeutics Inc. | 35 |
2 |
| The University of Melbourne | 569 |
2 |
| Massachusetts Institute of Technology | 10259 |
1 |
| University of Florida Research Foundation, Inc. | 4183 |
1 |
| ACADIA Pharmaceuticals Inc. | 192 |
1 |
| Altacor Limited | 11 |
1 |
| Amneal Pharmaceuticals LLC | 114 |
1 |
| CEMAG | 3 |
1 |
| The Chinese University of Hong Kong | 768 |
1 |
| Disphar International B.V. | 11 |
1 |
| Hybio Pharmaceutical Co., Ltd. | 121 |
1 |
| Imperial College Innovations Limited | 688 |
1 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3256 |
1 |
| Kissei Pharmaceutical Co., Ltd. | 177 |
1 |
| Other owners | 18 |